News | October 25, 2024
Mankind Pharma completes acquisition of BSV
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
To focus on providing safer burn treatments for women and armed forces
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
The total investment is in the region of Rs 200 crore
It is currently available in tablet and injectable dosage forms
Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Q3 FY25 revenue up 24% to Rs 3,230 crore
Revenue from Operations during Q2 FY25 was Rs. 3,077 crore as compared to Rs. 2,708 crore in Q2 FY24.
Subscribe To Our Newsletter & Stay Updated
